Page last updated: 2024-08-22

platinum and Alopecia

platinum has been researched along with Alopecia in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brunetti, C; Cassano, G; Colucci, G; Galetta, D; Gebbia, V; Germano, D; Giampaglia, M; Guida, M; Izzi, G; Lorusso, V; Nettis, G; Silvestris, N; Spada, M	1
Carter, SK	1

Reviews

1 review(s) available for platinum and Alopecia

Article	Year
Current status of new agents. Cancer chemotherapy reports. Part 3, 1972, Volume: 3, Issue:1 Topics: Alopecia; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Azacitidine; Azaguanine; Carmustine; Cyclohexanes; Drug Combinations; Heart; Humans; Leukemia L1210; Nitrosourea Compounds; Platinum; Prednisone; Remission, Spontaneous	1972

Trials

1 trial(s) available for platinum and Alopecia

Article	Year
Topotecan plus ifosfamide in patients with platinum refractory advanced/metastatic non-small cell lung cancer: a phase II trial. Oncology reports, 2005, Volume: 14, Issue:6 Topics: Adult; Aged; Alopecia; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; Female; Humans; Ifosfamide; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neutropenia; Platinum; Thrombocytopenia; Topotecan; Treatment Outcome	2005

Article

Year

Topotecan plus ifosfamide in patients with platinum refractory advanced/metastatic non-small cell lung cancer: a phase II trial.

Oncology reports, 2005, Volume: 14, Issue:6

Topics: Adult; Aged; Alopecia; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; Female; Humans; Ifosfamide; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neutropenia; Platinum; Thrombocytopenia; Topotecan; Treatment Outcome

2005